Korean J Nephrol.
2011 Nov;30(6):682-685.
Drug-induced Skin Hyperpigmentation after Usual Dosage of Bismuth-Containing Compound Medication in a Kidney Transplant Patient
- Affiliations
-
- 1Division of Nephrology, Department of Internal Medicine, Gil Medical Center, Gachon University of Medicine and Science, Korea. lhh90@gilhospital.com
Abstract
- A 59-year-old male presented with multiple hyperpigmented skin with hyperkeratotic scaly patches on hands, feet and face. Bismuth containing compound had been prescribed two months before then due to epigastric pain, an adverse effect of steroid pulse therapy for acute rejection of transplanted kidney. Laboratory findings showed acute kidney injury and elevated liver enzyme. He stopped taking bismuth containing compound and all symptoms were gone after two months. Although there is no report on interaction between bismuth and immunosuppressant, it requires precaution to prescribe bismuth containing compounds in transplanted patients with acute kidney injury.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Course of Bimatoprost-induced Periocular Skin Hyperpigmentation after Stopping Bimatoprost Treatment
- A Case of Lichenoid Drug Eruption Caused by Antituberculosis Drug
- A Case of Generalized Hyperpigmentation Caused by Antituberculosis Drugs
- A Case of Kaposi's Sarcoma Improved by Sirolimus Treatment in the Kidney Transplant Recipient
- A Concept Analysis of Compliance in Kidney Transplant Recipient Including Compliance with Immunosuppressive Medication
